.svg)
.svg)
We begin clinical trial recruitment in the UK
We have announced that the first patient in the UK has been enrolled to the CIBIL clinical trial !
Read moreWe obtain CE marking for our APILIFE solution
We, as a start-up specializing in predictive medicine devices, has obtained Class IIa CE marking for its Apilife solution
Read moreWe announced the first patient enrolled in our clinical trial !
This marks the beginning of this first-of-its-kind clinical trial conducted in Europe evaluating a digital health solution.
Read moreFrench start-up Cibiltech receives CE mark
The CE marking allows the company to market its medical device in all countries that recognize this certification...
Read more